Patent details

EP2350664 Title: TREATMENT OF CANCER USING THE HYPOXIA ACTIVATED PRODRUG TH-302 IN COMBINATION WITH DOCETAXEL OR PEMETREXED

Basic Information

Publication number:
EP2350664
PCT Application Number:
US2009061541
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP098226574
PCT Publication Number:
WO2010048330
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TREATMENT OF CANCER USING THE HYPOXIA ACTIVATED PRODRUG TH-302 IN COMBINATION WITH DOCETAXEL OR PEMETREXED
French Title of Invention:
TRAITEMENT DU CANCER À L'AIDE DU PROMÉDICAMENT ACTIVÉ PAR L'HYPOXIE TH-302 EN COMBINAISON AVEC LE DOCETAXEL OU LE PEMETREXED
German Title of Invention:
BEHANDLUNG VON KREBS ANHAND VOM HYPOXIE-AKTIVIERTEN PROMEDIKAMENT TH-302 IN KOMBINATIN MIT DOCETAXEL ODER PEMETREXED
SPC Number:

Dates

Filing date:
21/10/2009
Grant date:
19/05/2021
EP Publication Date:
03/08/2011
PCT Publication Date:
29/04/2010
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/05/2021
EP B1 Publication Date:
19/05/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
21/10/2021
Expiration date:
21/10/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/05/2021
 
 

Name:
ImmunoGenesis, Inc.
Address:
909 Fannin St Suite 2000, Houston TX 77010, United States (US)

Inventor

1

Name:
KROLL, Stewart
Address:
United States (US)

2

Name:
SUN, Jessica D.
Address:
United States (US)

3

Name:
CURD, John G.
Address:
United States (US)

4

Name:
DUAN, Jian-Xin
Address:
United States (US)

5

Name:
MATTEUCCI, Mark
Address:
United States (US)

6

Name:
HART, Charles P.
Address:
United States (US)

Priority

1

Priority Number:
107253 P
Priority Date:
21/10/2008
Priority Country:
United States (US)

2

Priority Number:
118368 P
Priority Date:
26/11/2008
Priority Country:
United States (US)

3

Priority Number:
150700 P
Priority Date:
06/02/2009
Priority Country:
United States (US)

4

Priority Number:
151163 P
Priority Date:
09/02/2009
Priority Country:
United States (US)

5

Priority Number:
244172 P
Priority Date:
21/09/2009
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/337; A61K 31/4985; A61K 31/513; A61K 31/519; A61K 31/555; A61K 31/675; A61K 31/704; A61K 31/7068; A61P 35/00; A61K 9/00; A61P 1/00; A61P 1/18; A61P 13/08; A61P 17/00; A61P 43/00; A61K 45/06; A61K 47/26; A61K 33/24;

Publication

European Patent Bulletin

Issue number:
202120
Publication date:
19/05/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages